FDA gives accelerated approval to AstraZeneca and Daiichi’s breast cancer drug
December 23, 2019Sales and Marketing AstraZeneca, Breast Cancer drug, Cancer, breast cancer, skin cancer
The FDA has approved the breast cancer drug Enhertu, developed by AstraZeneca and Daiichi Sankyo. José Basel, the Executive Vice …
Galderma Acne treatment receives approval from Europe
December 20, 2019Medical Communications Acne cream, Retinoid, acne
Galderma’s acne cream AKLIEF (trifarotene 50 mcg) has received approval by the European Union after reviewing its summary of product …
AstraZeneca sells Amrimidx and Casodex European rights to Juvisé Pharmaceuticals
December 20, 2019Medical Communications AstraZeneca, Cancer, Juvise, breast cancer, prostate cancer
AstraZeneca has announced that it has agreed to sell the rights to Arimidex (anastrozole) and Casodex (bicalutamide) in Europe, as …
FDA approves Merck & Co’s Ebola vaccine
December 20, 2019Medical Communications Ebola, Ebola Drug, Ebola West Africa, Ebola vaccine, Merck
The FDA has approved Merck & Co’s Ebola vaccine, Ervebo. This marks the first time they have approved a vaccine …
AbbVie granted EU marketing authorisation for new arthritis drug
December 19, 2019Business Services AbbVie, EC, EU, arthritis, rheumatoid arthritis
AbbVie have announced that the European Commission (EC) have granted marketing authorisation for RINVOQ (upadacitnib). It’s a daily selective reversible …
FDA approves Seattle Genetics and Astellas Pharma’s bladder cancer drug
December 19, 2019Business Services Astellas Pharma, Cancer, Padcev, Seattle Genetics, bladder cancer
The FDA has granted accelerated approval for Seattle Genetics and Astellas Pharma’s bladder cancer drug Padcev (enfortumab vedotin-ejfv). The drug’s …
AstraZeneca Vietnam obtains license to import pharmaceuticals
December 19, 2019Business Services AstraZeneca, AstraZeneca Vietnam, Vietnamese, vietnam
AstraZeneca Vietnam Co. Ltd becomes only the second multinational company in the country to obtain a license to import pharmaceuticals. …
Novartis plans giveaways of world’s most expensive drug
December 19, 2019Business Services Novartis, Zolgensma, sma
Novartis plans to giveaway 50 doses of the world’s costliest single-dose treatment, Zolgensma, for babies under 2 years old, with …
LSD treatment for Alzheimer’s patients proves safe in recent trial
December 19, 2019Business Services Alzheimer's, FDA, LSD, Magic mushrooms, psilocybin
The results of a Phase 1 clinical trial shows that Lysergic Acid Diethylamide (LSD) can be microdosed safely, and potentially …
Trump administration takes steps to allow cheaper drug imports from Canada
December 18, 2019Business Services Big Pharma, FDA, Trump, Trump Administraion, US Pharma
The Trump administration is close to allowing the import of some prescription Canadian drugs into the country.The FDA and the …
FDA advisory panel back Merck & Co.’s Keytruda treatment for bladder cancer
December 18, 2019Research and Development FDA, Merck, Merck and Co, NHS, NICE, keytruda
An FDA advisory committee voted 9 to 4 in favour of recommending Merk and Co’s Keytruda (pembrolizumab) for treatment in …
NHS Scotland gives green light to funding haemophilia A drug Hemlibra
December 18, 2019Research and Development NHS, haemophilia, haemophilia B, haemophilia a, nhs scotland
NHS Scotland has commissioned Hemlibra (emicizumab), by Chungai Pharma UK Ltd and Roche Products Ltd, to treat people with congenital …
Eli Lilly CEO says Elizabeth Warren’s claims they failed on cheaper insulin is ‘nonsense’
December 18, 2019Research and Development Bernie Sanders, Eli Lilly, Elizabeth Warren, US Pharma, US Presidential Election, insulin
David Ricks, the CEO of Eli Lilly, has said that Presidential candidate Senator Elizabeth Warren’s claims his company failed on …
FDA advisory committee approves the use of Lynparza in pancreatic cancer
December 18, 2019Research and Development AstraZeneca, Cancer, Merck, Pancreatic cancer, lynparza
The FDA’s Oncologic Drugs Advisory Committee (ODAC) has recommended the approval of AstraZeneca and Merck’s Lynparza (olaparib) to treat pancreatic …
Novartis abandons asthma drug after Phase 3 trial results
December 17, 2019Manufacturing and Production Novartis, Novartis. R&D, asthma, novartis r&d
Novartis have said it is not going forward with a new asthma drug, as the treatement failed its Phase 3 …
Irish haemophilia A patients to get continued access to Sobi’s extended half-life factor replacement therapy
December 17, 2019Manufacturing and Production haemophilia, haemophilia B, haemophilia a
The Republic of Ireland’s Haemophilia Product Selection and Monitoring Advisory Board (HPSMAB) and Sobi United Kingdom and Republic of Ireland, …
Sackler family withdrew $10 billion from Purdue Pharma while legal pressure mounted, audit shows
December 17, 2019Manufacturing and Production Oxy, OxyContin, Purdue Pharma, Sackler family, opioid, opioid crisis, sackler
An audit commissioned by Purdue Pharma, to help navigate its bankruptcy, indicates that members of the Sackler family withdrew $10.7 …
FDA approves Pfizer and Astellas Pharma’s prostate cancer drug
December 17, 2019Manufacturing and Production Astellas Pharma, Cancer, FDA, Pfizer, Xtandi, prostate cancer
The FDA has approved Pfizer and Astellas Pharma’s Xtandi (enzalutamide) to treat patients with a type of prostate cancer. The …
British Pharmacists call for regulation on non-medicinal CBD products
December 17, 2019Manufacturing and Production CBD, CBD Oil, CBD Products, cannabis
Pharmacists are calling for more checks on products containing Cannabis derivative cannabidiol (CBD) that are sold in shops across the …
Roche’s Tecentriq combo boosts progression-free survival in previously untreated BRAF V600 mutation-positive advanced melanoma
December 16, 2019Manufacturing and Production, Research and Development, Sales and Marketing Roche, melanoma, pharma, tecentriq
Roche has lifted the curtain on new Phase 3 data for its immunotherapy Tecentriq (atezolizumab), confirming that the therapy, when …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
